Immunocore Holdings Cash Flow Statement (2021-2026) | IMCR

Cash Flow Statement Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -41.54M-53.10M-19.69M7.34M-29.87M-19.46M-17.62M0.91M-19.73M-24.48M-11.63M8.74M-23.77M4.98M-10.30M-0.20M-30.06M12.97M
Depreciation and Depletion (Quarter) 2.32M1.74M1.57M0.95M1.03M1.08M1.03M1.01M0.99M1.03M1.17M0.85M0.78M0.80M0.83M0.95M
Share-based Compensation (Quarter) 12.68M11.76M9.34M7.18M8.06M8.26M8.75M8.20M7.19M8.96M10.00M6.56M8.67M9.49M10.03M9.84M8.34M6.30M
Non-cash Items (Quarter) -0.17M-0.19M1.62M
Change in Working Capital (Quarter) -0.15M0.15M0.08M
Change in Receivables (Quarter) -4.67M-5.98M-8.29M3.58M3.60M0.47M10.22M6.20M2.66M2.19M1.29M-0.84M4.18M5.99M-1.99M7.93M
Change in Account Payables (Quarter) 8.61M18.89M13.19M-3.02M5.98M-4.09M3.75M-2.32M4.48M-0.78M5.88M3.34M-6.93M-0.29M1.42M5.97M
Change in Accured Expenses (Quarter) 4.58M7.30M11.23M15.98M19.17M26.86M26.70M-1.23M-10.94M33.73M15.13M-22.03M-8.30M
Other Working Capital Changes (Quarter) -18.14M2.44M-2.35M27.22M1.82M2.24M1.85M5.69M1.57M-5.10M9.25M1.02M18.77M
Cash from Operations (Quarter) -38.71M9.54M7.08M10.54M0.04M10.09M-17.73M-4.59M23.47M21.13M-13.95M0.43M25.96M-4.46M-32.66M-13.78M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges (Quarter) 0.41M0.40M0.40M0.44M0.43M0.43M0.49M0.56M0.55M0.57M0.57M0.67M0.63M
Depreciation & Amortization (CF) (Quarter) 2.32M1.74M1.57M0.95M1.08M1.03M1.01M0.99M1.03M1.17M0.85M0.78M0.80M0.83M0.95M
Investing Activities
Capital Expenditures (Quarter) 0.37M0.46M1.08M3.00M1.40M0.21M0.82M0.43M0.33M0.83M3.58M0.30M0.41M0.75M2.88M1.78M
Sales of Property, Plant and Equipment (Quarter) 0.02M
Change in Acquisitions & Divestments (Quarter) 1.95M10.00M6.00M2.00M6.00M
Cash from Investing Activities (Quarter) -0.36M0.24M0.39M-3.00M-1.40M-0.21M-0.82M-0.43M-350.33M-0.83M-3.54M9.70M-30.41M5.25M-0.88M4.22M
Financing Activities
Other financing activities (Quarter) 6.14M11.58M10.38M6.25M5.75M0.30M0.20M0.55M2.55M3.67M1.87M4.28M0.66M
Cash from Financing Activities (Quarter) -2.78M138.50M-1.40M6.14M11.58M10.38M6.25M396.01M-0.82M0.20M-51.51M2.55M3.67M1.87M4.28M0.66M
Additional items
Exchange Rate Effect (Quarter) -0.01M15.69M-23.25M2.23M3.39M-8.11M10.78M-0.80M-0.16M12.29M-13.03M8.43M11.87M7.82M-1.45M-6.13M
Change in Cash (Quarter) -25.15M148.28M6.07M13.68M10.23M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M
Free Cash Flow (Quarter) -39.08M9.07M6.00M7.54M9.88M-18.55M-5.02M23.14M20.30M-17.54M0.14M25.55M-5.20M-35.53M-15.56M
Net Cash Flow (Quarter) -41.84M148.28M6.07M13.68M20.25M-12.30M391.00M-327.68M20.50M-69.00M12.69M-0.78M2.66M-29.25M-8.90M